EUVIMEDEUVIMED entdecken
Crossref

Oncogenic role and potential mechanisms of MYO1B in breast cancer

Mei Dai, Qin Jiang, Danhua Zhang, Lun Li

In Vitro Cellular & Developmental Biology - Animal · 2026-04 · 62 (4) · 428-443

DOI: 10.1007/s11626-025-01149-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift In Vitro Cellular & Developmental Biology - Animal, online erschienen am 15.04.2026. Verfasst von Mei Dai und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Second Xiangya Hospital, Central South University, Danhua Zhang, No. 139 Middle People Road, Changsha, 410011, Hunan, …. Hauptthemen laut MEDLINE: Breast Neoplasms, Myosin Type I, Carcinogenesis, Oncogenes. Die Arbeit nennt 63 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myosin IB (MYO1B), a member of the type I myosin family, is overexpressed in various tumor tissues. MYO1B facilitates tumor progression by regulating cellular proliferation, migration, and the epithelial-mesenchymal transition (EMT). However, the precise function of MYO1B in breast cancer (BRCA) is still not well understood. We analyzed MYO1B expression, prognostic significance, immune infiltration, and its correlation with drug resistance in BRCA using meta-analysis and public databases. Functional assays in BRCA cells were performed to evaluate the effects of MYO1B on cell proliferation, apoptosis, and sensitivity to tamoxifen and palbociclib. MYO1B mRNA levels showed no significant difference between BRCA and normal tissues, whereas MYO1B protein was upregulated in tumor tissues. High MYO1B expression was associated with poor prognosis in BRCA patients. Functionally, MYO1B promoted BRCA cell proliferation, inhibited apoptosis, and increased resistance to tamoxifen and palbociclib. Mechanistically, MYO1B activated the Pi3k-AKT signaling pathway. Our study suggests that MYO1B promotes the progression of BRCA and may serve as a new target for overcoming endocrine therapy resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsMyosin Type ICarcinogenesisOncogenesHumansFemaleGene Expression Regulation, NeoplasticCell ProliferationApoptosisCell Line, TumorDrug Resistance, NeoplasmSignal TransductionPrognosisPhosphatidylinositol 3-KinasesTamoxifenProto-Oncogene Proteins c-aktCell Movement

Stichwörter der Autor:innen

Breast cancerDrug resistanceMYO1BOncogenesisPrognosis

Substanzen

Myosin Type IMYO1B protein, humanPhosphatidylinositol 3-KinasesTamoxifenProto-Oncogene Proteins c-akt

Autor:innen und Institutionen

  • Department of General Surgery, Second Xiangya Hospital, Central South University, Danhua Zhang, No. 139 Middle People Road, Changsha, 410011, Hunan, China.
  • Department of General Surgery, Second Xiangya Hospital, Central South University, Danhua Zhang, No. 139 Middle People Road, Changsha, 410011, Hunan, China. zhangdanhua@csu.edu.cn.
  • Department of General Surgery, Second Xiangya Hospital, Central South University, Danhua Zhang, No. 139 Middle People Road, Changsha, 410011, Hunan, China. lilun6830@csu.edu.cn.

Zitieren

APA

Dai, M., Jiang, Q., Zhang, D., & Li, L. (2026). Oncogenic role and potential mechanisms of MYO1B in breast cancer. In Vitro Cellular & Developmental Biology - Animal, 62(4), 428-443. https://doi.org/10.1007/s11626-025-01149-5

Vancouver

Dai M, Jiang Q, Zhang D, Li L. Oncogenic role and potential mechanisms of MYO1B in breast cancer. In Vitro Cellular & Developmental Biology - Animal. 2026;62(4):428-443. doi:10.1007/s11626-025-01149-5

BibTeX
@article{Dai2026,
  author = {Dai, Mei and Jiang, Qin and Zhang, Danhua and Li, Lun},
  title = {Oncogenic role and potential mechanisms of MYO1B in breast cancer},
  journal = {In Vitro Cellular & Developmental Biology - Animal},
  year = {2026},
  volume = {62},
  number = {4},
  pages = {428--443},
  doi = {10.1007/s11626-025-01149-5}
}
Kostenlos starten →